Gonda 8-104/Joseph 1-242

Headache
Aaron Bubolz, D.O.
Ivan Garza, M.D.
"Migraine Prophylaxis and CGRP Antibodies"

Learning objectives:
Review pharmacologic migraine prevention strategiessss
Review available migraine prevention guidelines
Summarize data on CGRP antibodies as potential new migraine preventives
Identify science of CGRP
Review pathophysiology of CGRP in headache medicine
Review current literature regarding CGRP and headache

The presenters (nor spouses/partners) do not have a relevant financial relationship to disclose.
Dr. Bubolz does not intend to discuss an off-label/investigative use of a commercial product/device.
Dr. Garza does intend to discuss off-label/investigative uses of the following commercial products/devices:
Manufacturers/Providers: multiple manufacturers; Products/Devices: sodium valproate, metoprolol, amitriptyline, venlafaxine, atenolol, nadolol, lisinopril, candesartan, clonidine, guanfacine, carbamazepine, nebivolol, pindolol, cyproheptadine, acetazolamide, coumadin, gabapentin, protriptyline, bisoprolol, verapamil, lamotrigine, clonazepam, oxcarbazepine, telmisartan, Petasites, magnesium, feverfew, riboflavin, coenzyme Q10, omega-3, frovatriptan, naratriptan, zolmitriptan, estrogen, indomethacin, ketoprofen, naproxen sodium